
- Teaching Hospital
- Pharmacy Home
- Administrative Resources
- Controlled Substances
- Regulatory Resources
- Floor Stock Requests
- Drug and Supplies Fair
- Drug Information
- Calendar
- Commercial Resources
- Drug/Supply Shortages
USE OF TEACHING HOSPITAL DRUGS AND SUPPLIES
Application of The Robinson-Patman and Prescription Drug Marketing Acts
The Short Version
We can sell, use, or dispense drugs and supplies purchased by or given to the
University for medically appropriate indications to inpatients of the
hospital, outpatients of the hospital during medically appropriate visits
at the hospital, local full service patients (for up to a year following
the last visit), “dependent” animals wholly owned by and cared for by faculty,
students and staff of the College of Veterinary Medicine, and to University
departments for research or teaching uses.
We can not sell or dispense drugs and supplies purchased by
or given to the University to walk in customers, friends, neighbors or
family members of faculty, staff or students of the college of Veterinary
Medicine (unless the patient fits one of the categories listed above),
veterinarians associated with the University for activities not related to
University functions, veterinarians not associated with the University,
refills of prescriptions or sales of nonprescription items for patients
not being seen as inpatients or outpatients of the hospital at the time, or
any other use.
We often get requests to refill prescriptions for referral clients because
the client has not been able to locate a source for a drug. The pharmacy
will gladly assist the client in locating a source for the drug(s).
We also get requests from veterinary practitioners to sell drugs to them.
We can not sell drugs, but we maintain a loan/borrow system that allows
us to provide drugs to the practitioners for emergency needs. The drugs
or supplies are replaced in kind.
These restrictions often seem overly restrictive to clients and hospital
staff, but there are legal and practical reasons for them and the penalties
for violations are severe. Please consult the pharmacy if you feel that
the restrictions are preventing you from providing care to your patients.
The Long Version
The pharmacy frequently receives requests to sell items to, or for
prescriptions to be filled for animals which belong to a neighbor,
friend, colleague, or relative, or for other animals which are not
patients of the Teaching Hospital. We also are frequently requested
to provide drugs or supplies to veterinarians, veterinary practices,
or other institutions not connected with the Teaching Hospital. Such
uses of drug stocks constitute violations of federal law and can result
in significant civil and criminal penalties.
The Robinson-Patman
Act (part of the
Clayton Antitrust Act) prohibits
price discrimination by sellers of commodities. However, the
Nonprofit
Institutions Act provides an exemption from price discrimination
restrictions for certain nonprofit institutions when commodities are
purchased “for their own use.” The Teaching Hospital purchases drugs
and supplies at noncompetitive prices based upon this exemption.
The Prescription
Drug Marketing Act (in the Food, Drug and Cosmetic Act)
prohibits the sale, purchase, or trade, or the offer to sell, purchase
or trade, certain drugs obtained under the exemption of the Nonprofit
Institutions Act. These drugs can be transferred between agencies
within the same buying group or dispensed pursuant to a lawful
prescription if the prescription falls within the "own use" requirement.
However, virtually any other use is prohibited.
The words for their own use in the context of hospital uses of drugs
have been defined in case law and by Federal Trade Commission advisory
opinions. None of the aforementioned uses are allowed under the exemption
of the Nonprofit Institutions Act.
The following uses have been defined to be “for our own use” and also
meet the requirements of the Prescription Drug Marketing Act:
1) dispensation to the hospital inpatient for use in his treatment
at the hospital
2) dispensation to the patient admitted to the hospital emergency
facility for use in the patient's treatment there
3) dispensation to the hospital outpatient for personal use on the
hospital premises
4) dispensation in the context of a genuine take-home prescription,
intended for a limited and reasonable time, as a continuation or
supplement to, the treatment that was administered at the hospital
to the recipient while an inpatient, an outpatient or an emergency
facility patient if the patient needed, and now continues to need,
that treatment
5) dispensation to the hospital's employee(s) or to its student(s)
for their personal use or for the personal use of their dependents
6) dispensation to a physician member of the medical staff for
his personal use or for the personal use of his dependents
7) dispensation by a health maintenance organization to its members
One situation is specifically allowed under the Prescription Drug
Marketing Act and though it is not covered by the Robinson-Patman Act,
appears to be permissible (but has not been tested in the courts):
1) dispensation by a nonprofit institution to the general public
for humanitarian purposes in emergency situations when other sources
of the products are not available.
Several types of dispensation have been defined as not permissible:
1) dispensation in the context of a prescription refill for a former
hospital patient
2) dispensation to a physician member of the medical staff for his
use in a private practice unconnected with the hospital, or for any
other nonpersonal use
3) dispensation to the walk-in buyer at a hospital pharmacy
4) dispensation by a nonprofit hospital to other entities outside
of its buying group
5) dispensation by state and local government hospitals to the
general public
The penalties for violations are substantial. They can include:
1) termination of price discounts, recall of products in stock,
and financial liability for fines and penalties paid by sellers and
requirements to repay the difference between discounted prices and
competitive prices for past purchases
2) criminal prosecution under the Clayton Act ($100,000-500,000
fine, 1 year in prison)
3) criminal prosecution under the Prescription Drug Marketing Act
(a felony punishable by a $250,000-500,000 fine and up to 10 years
in prison.)
4) civil suits by competitors (treble damages + legal expenses + interest)
5) civil and criminal prosecution for fraudulent misrepresentation
6) prosecution under the
Racketeering Influenced and Corrupt Organizations Act (RICO), subject to treble damages and divestiture
penalties. (Two violations in a ten year period are all that is
required for prosecution.)
7) financial responsibility for injury to the ultimate user of the
product
8) civil and criminal prosecution under the Federal Food, Drug and
Cosmetic Act if the product becomes adulterated or misbranded, even
if participation in such activities was unintentional or was
undertaken without knowledge of the consequences. (Any person
who adulterates or misbrands a drug, as well as anyone who introduces,
delivers or receives drugs which have been or will be misbranded
or adulterated is subject to prosecution.) ($100,000-500,000 fine,
1 year in jail for misdemeanor, 10 years for felony violations)
Application of these laws in a veterinary hospital setting is very
direct in some situations and requires extrapolation in others.
It is clear that commodities purchased under the exemptions
may be used to treat inpatients, outpatients and emergency
patients of the hospital, to dispense reasonable amounts of drugs
as go home prescriptions and to provide drugs to the general public
in valid emergencies. It is equally clear that they may not be used
to refill prescriptions for referral cases after they are discharged
from the hospital, fill prescriptions written by practitioners who
are not connected with the hospital, provide drugs or supplies to
individuals or institutions not connected with the hospital, or to
provide drugs or supplies to practitioners associated with the
hospital if they are to be used on patients not associated with
the hospital.
Clearly animals can not be considered to be patients of the hospital
in the absence of a valid veterinarian-client-patient relationship.
This relationship was originally defined by the American Veterinary
Medical Association and the definition has been accepted by the Food
and Drug Administration, the Georgia Board of of Veterinary Medicine, the
Georgia Veterinary Medical Association and carries the force of law
through the
AMDUCA regulations.
A valid veterinarian-client-relationship is one in which:
1) A veterinarian has assumed the responsibility for making medical
judgments regarding the health of (an) animal(s) and the need for
medical treatment, and the client (the owner of the animal or animals or
other caretaker) has agreed to follow the instructions of the
veterinarian;
2) There is sufficient knowledge of the animal(s) by the
veterinarian to initiate at least a general or preliminary diagnosis of
the medical condition of the animal(s); and
3) The practicing veterinarian is readily available for followup in
case of adverse reactions or failure of the regimen of therapy. Such a
relationship can exist only when the veterinarian has recently seen and
is personally acquainted with the keeping and care of the animal(s) by
virtue of examination of the animal(s), and/or by medically appropriate
and timely visits to the premises where the animal(s) are kept.
Commodities purchased under the exemptions may be used for research and
teaching activities by other schools, colleges and departments of the
University, since they are in the same buying group. However, they
may not be provided to non-university institutions even if they are
engaged in research with the university. Some vendors also restrict
use of certain commodities to the College of Veterinary Medicine as
a requirement to qualify for special prices.
Hospital and College policy allows faculty, students and staff of
the College of Veterinary Medicine to obtain drugs and supplies from
the hospital for treatment of their personal animals. This requires
acceptance of the concept that these animals are "dependents" of a
member of the "hospital family." To meet this requirement the
animals in question must be wholly owned by the member of the
hospital family and that member must have total financial
responsibility for the care of the animal. Clearly, the pet
animal living at the member's residence would fit this interpretation,
whereas the syndicated breeding animal would not.
Protection of our exemption from price discrimination laws is of
great financial importance to the teaching program at the College
of Veterinary Medicine. Since personnel in the pharmacy and the
hospital director's office are often required to sign agreements
with suppliers that the commodities will be used for our "own use"
as defined by law, compliance is very important to the pharmacy.
For these reasons, pharmacy staff members may not fill requests
for drugs or supplies if there is doubt as to whether the requests
comply with permissible uses under these laws.
References
1. American Hospital Association Office of General Council, Legal
Implications of Hospital Resales of Pharmaceuticals, Am J Hosp Pharm.
1986;43:1951-1957.
2. 15 U.S.C. Sec 13.
3. 425 U.S. 1 (1976).
4. 460 U.S. 150 (1983).
5.
18 U.S.C. Sec. 1961 et seq.
6. Greenberg, RB, Robinson-Patman Update: DeModena v. Kaiser
Foundation Health Plan, Am J Hosp Pharm. 1985;42:1572-1574.
7. P.L. 100-293 (100th Cong.,2nd ses., 1988), 102 Stat.95,
amending the Federal Food,Drug and Cosmetic Act, 21 USC 301 et seq
